Mexico Compounding Pharmacies Market (2025 - 2030) Size, Share & Trends Analysis Report By Therapeutic Area, By Age Cohort (Pediatric, Geriatric), By Compounding Type (Pharmaceutical Ingredient Alteration (PIA)), By Sterility, And Segment Forecasts

Table of Contents

Chapter 1. Methodology and Scope
                    1.1. Market Segmentation & Scope
                        1.1.1. Segment Definitions
                    1.2. Estimates and Forecast Timeline
                    1.3. Research Methodology
                    1.4. Information Procurement
                        1.4.1. Purchased Database
                        1.4.2. GVR’s Internal Database
                        1.4.3. Secondary Sources
                        1.4.4. Primary Research
                        1.4.5. Details of Primary Research
                        1.4.6. Research Assumption
                    1.5. Information or Data Analysis
                        1.5.1. Data Analysis Models
                    1.6. Market Formulation & Data Visualization
                    1.7. Model Details
                        1.7.1. Commodity Flow Analysis
                    1.8. Objectives
                        1.8.1. Objective - 1
                        1.8.2. Objective - 2
                        1.8.3. Objective - 3
                    1.9. List of Secondary Sources
                    1.10. List of Abbreviations
Chapter 2. Executive Summary
                    2.1. Mexico Compounding Pharmacies Market
                        2.1.1. Market Snapshot
                        2.1.2. Segment Snapshot
                            2.1.2.1. Therapeutic area segment outlook
                            2.1.2.2. Age cohort segment outlook
                            2.1.2.3. Type segment outlook
                            2.1.2.4. Sterility segment outlook
                        2.1.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
                    3.1. Market Lineage Outlook
                        3.1.1. Parent Market Outlook
                    3.2. Market Trends and Outlook
                    3.3. Market Dynamics
                        3.3.1. Market Driver Analysis
                            3.3.1.1. Increasing demand for personalized medication
                            3.3.1.2. Increasing importance of pharmaceutical compounding in promoting medical adherence
                            3.3.1.3. Increasing collaboration with healthcare providers
                            3.3.1.4. Rising prevalence of chronic and infectious diseases
                        3.3.2. Market Restraint Analysis
                            3.3.2.1. Risk of chemical contamination
                            3.3.2.2. Lack of awareness and limited access to compounded medication
                    3.4. Regulatory Framework
                    3.5. Business Environment Analysis Tools
                        3.5.1. Industry Analysis - Porter’s Five Forces Analysis
                            3.5.1.1. Supplier power
                            3.5.1.2. Buyer power
                            3.5.1.3. Substitution threat
                            3.5.1.4. Threat of new entrant
                            3.5.1.5. Competitive rivalry
                        3.5.2. PESTEL Analysis
Chapter 4. Therapeutic Area Business Analysis
                    4.1. Mexico Compounding Pharmacies Market: Therapeutic Area Movement Analysis
                    4.2. Mexico Compounding Pharmacies Market: Therapeutic Area Segment Dashboard
                    4.3. Therapeutic Area Movement & Market Share Analysis, 2024 & 2030
                    4.4. Mexico Compounding Pharmacies Market Estimates & Forecast, by Therapeutic Area
                    4.5. Hormone Replacement Therapy
                        4.5.1. Hormone Replacement Therapy Market, 2018 - 2030 (USD Million)
                    4.6. Pain Management
                        4.6.1. Pain Management Market, 2018 - 2030 (USD Million)
                    4.7. Specialty Drugs
                        4.7.1. Specialty Drugs Market, 2018 - 2030 (USD Million)
                    4.8. Dermatology
                        4.8.1. Dermatology Market, 2018 - 2030 (USD Million)
                    4.9. Nutritional Supplements
                        4.9.1. Nutritional Supplements Market, 2018 - 2030 (USD Million)
                    4.10. Others
                        4.10.1. Others Market, 2018 - 2030 (USD Million)
Chapter 5. Age Cohort Business Analysis
                    5.1. Mexico Compounding Pharmacies Market: Age Cohort Movement Analysis
                    5.2. Mexico Compounding Pharmacies Market: Age Cohort Segment Dashboard
                    5.3. Age Cohort Movement & Market Share Analysis, 2024 & 2030
                    5.4. Mexico Compounding Pharmacies Market Estimates & Forecast, by Age Cohort
                    5.5. Pediatric
                        5.5.1. Pediatric Market, 2018 - 2030 (USD Million)
                    5.6. Adult
                        5.6.1. Adult Market, 2018 - 2030 (USD Million)
                    5.7. Geriatric
                        5.7.1. Geriatric Market, 2018 - 2030 (USD Million)
Chapter 6. Type Business Analysis
                    6.1. Mexico Compounding Pharmacies Market: Type Movement Analysis
                    6.2. Mexico Compounding Pharmacies Market: Type Segment Dashboard
                    6.3. Type Movement & Market Share Analysis, 2024 & 2030
                    6.4. Mexico Compounding Pharmacies Market Estimates & Forecast, by Type
                    6.5. Pharmaceutical Ingredient Alteration (PIA)
                        6.5.1. Pharmaceutical Ingredient Alteration (PIA) Market, 2018 - 2030 (USD Million)
                    6.6. Currently Unavailable Pharmaceutical Manufacturing (CUPM)
                        6.6.1. Currently Unavailable Pharmaceutical Manufacturing (CUPM) Market, 2018 - 2030 (USD Million)
                    6.7. Pharmaceutical Dosage Alteration (PDA)
                        6.7.1. Pharmaceutical Dosage Alteration (PDA) Market, 2018 - 2030 (USD Million)
                    6.8. Others
                        6.8.1. Others Market, 2018 - 2030 (USD Million)
Chapter 7. Sterility Business Analysis
                    7.1. Mexico Compounding Pharmacies Market: Sterility Movement Analysis
                    7.2. Mexico Compounding Pharmacies Market: Sterility Segment Dashboard
                    7.3. Sterility Movement & Market Share Analysis, 2024 & 2030
                    7.4. Mexico Compounding Pharmacies Market Estimates & Forecast, by Sterility
                    7.5. Sterile
                        7.5.1. Sterile Market, 2018 - 2030 (USD Million)
                    7.6. Non-Sterile
                        7.6.1. Non-Sterile Market, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
                    8.1. Company Categorization
                    8.2. Company Market Position Analysis
                    8.3. Company Share Analysis
                    8.4. Strategy Mapping
                        8.4.1. Partnership/Collaboration/Alliance
                        8.4.2. New Service Launch
                        8.4.3. Mergers & Acquisitions
                        8.4.4. Others
                    8.5. Company Profiles/Listing
                        8.5.1. Fagron (Brands & Essentials)
                            8.5.1.1. Overview
                            8.5.1.2. Financial performance
                            8.5.1.3. Service benchmarking
                            8.5.1.4. Strategic initiatives
                        8.5.2. Omicronlab
                            8.5.2.1. Overview
                            8.5.2.2. Financial performance
                            8.5.2.3. Service benchmarking
                            8.5.2.4. Strategic initiatives
                        8.5.3. Magistral Pharmacies
                            8.5.3.1. Overview
                            8.5.3.2. Financial performance
                            8.5.3.3. Service benchmarking
                            8.5.3.4. Strategic initiatives
                        8.5.4. BIOH
                            8.5.4.1. Overview
                            8.5.4.2. Financial performance
                            8.5.4.3. Service benchmarking
                            8.5.4.4. Strategic initiatives
                        8.5.5. FarmaLife
                            8.5.5.1. Overview
                            8.5.5.2. Financial performance
                            8.5.5.3. Service benchmarking
                            8.5.5.4. Strategic initiatives
                        8.5.6. Farmacia México
                            8.5.6.1. Overview
                            8.5.6.2. Financial performance
                            8.5.6.3. Service benchmarking
                            8.5.6.4. Strategic initiatives
                        8.5.7. Pharma Tycsa
                            8.5.7.1. Overview
                            8.5.7.2. Financial performance
                            8.5.7.3. Service benchmarking
                            8.5.7.4. Strategic initiatives
                        8.5.8. Compounding Wholesalers de México
                            8.5.8.1. Overview
                            8.5.8.2. Financial performance
                            8.5.8.3. Service benchmarking
                            8.5.8.4. Strategic initiatives
                        8.5.9. MXPharmacy (Edge Pharma)
                            8.5.9.1. Overview
                            8.5.9.2. Financial performance
                            8.5.9.3. Service benchmarking
                            8.5.9.4. Strategic initiatives
                        8.5.10. Farmacias el Globo
                            8.5.10.1. Overview
                            8.5.10.2. Financial performance
                            8.5.10.3. Service benchmarking
                            8.5.10.4. Strategic initiatives
                        8.5.11. DermiCo
                            8.5.11.1. Overview
                            8.5.11.2. Financial performance
                            8.5.11.3. Service benchmarking
                            8.5.11.4. Strategic initiatives
                        8.5.12. Bionorusso
                            8.5.12.1. Overview
                            8.5.12.2. Financial performance
                            8.5.12.3. Service benchmarking
                            8.5.12.4. Strategic initiatives
                        8.5.13. Hervanario
                            8.5.13.1. Overview
                            8.5.13.2. Financial performance
                            8.5.13.3. Service benchmarking
                            8.5.13.4. Strategic initiatives

List of Tables

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Mexico compounding pharmacies market revenue estimates and forecast, by therapeutic area, 2018 - 2030 (USD Million)
Table 4 Mexico compounding pharmacies market revenue estimates and forecast, by age cohort, 2018 - 2030 (USD Million)
Table 5 Mexico compounding pharmacies market revenue estimates and forecast, by type, 2018 - 2030 (USD Million)
Table 6 Mexico compounding pharmacies market revenue estimates and forecast, by sterility, 2018 - 2030 (USD Million)

List of Figures

Fig. 1 Mexico compounding pharmacies market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value chain based sizing & forecasting
Fig. 7 QFD modelling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market snapshot
Fig. 10 Therapeutic area segment outlook
Fig. 11 Competitive landscape
Fig. 12 Mexico compounding pharmacies market: Market dynamics
Fig. 13 Mexico compounding pharmacies market: Porter’s analysis
Fig. 14 Mexico compounding pharmacies market: PESTLE analysis
Fig. 15 Mexico compounding pharmacies market: Therapeutic area segment dashboard
Fig. 16 Mexico compounding pharmacies market: Therapeutic area movement share analysis
Fig. 17 Hormone replacement therapy market, 2018 - 2030 (USD Million)
Fig. 18 Pain management market, 2018 - 2030 (USD Million)
Fig. 19 Specialty drugs market, 2018 - 2030 (USD Million)
Fig. 20 Dermatology market, 2018 - 2030 (USD Million)
Fig. 21 Nutritional Supplements market, 2018 - 2030 (USD Million)
Fig. 22 Others market, 2018 - 2030 (USD Million)
Fig. 23 Mexico compounding pharmacies market: Age cohort segment dashboard
Fig. 24 Mexico compounding pharmacies market: Age cohort movement share analysis
Fig. 25 Pediatric market, 2018 - 2030 (USD Million)
Fig. 26 Adult market, 2018 - 2030 (USD Million)
Fig. 27 Geriatric market, 2018 - 2030 (USD Million)
Fig. 28 Mexico compounding pharmacies market: Type segment dashboard
Fig. 29 Mexico compounding pharmacies market: Type movement share analysis
Fig. 30 Pharmaceutical Ingredient Alteration (PIA)
Fig. 31 Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Fig. 32 Pharmaceutical Dosage Alteration (PDA)
Fig. 33 Others market, 2018 - 2030 (USD Million)
Fig. 34 Mexico compounding pharmacies market: Sterility segment dashboard
Fig. 35 Mexico compounding pharmacies market: Sterility movement share analysis
Fig. 36 Sterile market, 2018 - 2030 (USD Million)
Fig. 37 Non sterile market, 2018 - 2030 (USD Million)
Fig. 38 Company categorization
Fig. 39 Company market position analysis
Fig. 40 Strategic framework